Search results for "Diabetes"
Register for ACP's new one-day virtual diabetes course
Internists who attend “Diabetes for the Internist: ACP Virtual Live” will learn the latest information on caring for patients with diabetes, gain CME/MOC, and have their clinical questions answered by experts in the field.
https://immattersacp.org/weekly/archives/2021/05/18/5.htm
18 May 2021
Salt tablets no salve for hyponatremia
At Kidney Week in fall 2023, an endocrinologist covered the latest in outpatient diagnosis and treatment of syndrome of inappropriate antidiuresis (SIAD).
https://immattersacp.org/archives/2024/02/salt-tablets-no-salve-for-hyponatremia.htm
1 Feb 2024
USPSTF lowers age for starting diabetes screening from 40 to 35 years
Primary care clinicians should screen all overweight or obese adults ages 35 to 70 years for diabetes and prediabetes and should offer interventions for those with either condition, the U.S. Preventive Services Task Force (USPSTF) recently recommended.
https://immattersacp.org/weekly/archives/2021/08/31/2.htm
31 Aug 2021
Keep a close eye on the kidneys in diabetes
Screening and adherence to best prescribing practices offer two key ways to prevent or slow the progression of chronic kidney disease in patients with diabetes.
https://immattersacp.org/archives/2020/09/keep-a-close-eye-on-the-kidneys-in-diabetes.htm
1 Sep 2020
Register now for ACP webinar on CGM for type 2 diabetes management in primary care
An ACP webinar on June 15 will teach primary care clinicians how to identify good candidates for continuous glucose monitoring (CGM) and how to use CGM data to empower patients to improve their type 2 diabetes self-management.
https://immattersacp.org/weekly/archives/2021/05/25/6.htm
25 May 2021
‘Goldilocks' goal for diabetes and CKD
Managing kidney disease in diabetes requires meeting individualized parameters and balancing risks in nephrology and cardiology. Learn whether more aggressive treatment is warranted in this population.
https://immattersacp.org/archives/2012/11/diabetes.htm
1 Nov 2012
GLP-1 receptor agonists may offer kidney protection in patients with type 2 diabetes
An industry-conducted pooled analysis of two large trials of glucagon-like peptide-1 (GLP-1) receptor agonists found that both semaglutide and liraglutide slowed kidney function decline, with semaglutide appearing to have the greatest effect.
https://immattersacp.org/weekly/archives/2021/12/21/2.htm
21 Dec 2021
Study suggests less frequent retinopathy screening in low-risk patients with type 1 diabetes
Annual screening led to an average of 18.4 exams up to time of detection of proliferative diabetic retinopathy and clinically significant macular edema, compared to 7.7 exams with an individualized schedule, for an average reduction of 10.7 exams per patient (58% fewer).
https://immattersacp.org/weekly/archives/2017/04/25/4.htm
25 Apr 2017
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2023/10/latest-updates-on-acps-priorities-initiatives.htm
1 Oct 2023
More compounded products recalled, diabetes drug approved
This regulatory update covers a recall of a compounding pharmacy's products due to mold and approval of a sodium-glucose co-transporter for diabetes.
https://immattersacp.org/archives/2013/06/fda.htm
1 Jun 2013